POLYRIZON LTD (PLRZ) Fundamental Analysis & Valuation

NASDAQ:PLRZ • IL0011814113

13.11 USD
-0.5 (-3.67%)
Last: Mar 6, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PLRZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PLRZ. PLRZ was compared to 520 industry peers in the Biotechnology industry. While PLRZ has a great health rating, there are worries on its profitability. PLRZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. PLRZ Profitability Analysis

1.1 Basic Checks

  • PLRZ had negative earnings in the past year.
  • In the past year PLRZ has reported a negative cash flow from operations.
PLRZ Yearly Net Income VS EBIT VS OCF VS FCFPLRZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -500K -1M -1.5M

1.2 Ratios

  • The Return On Assets of PLRZ (-9.51%) is better than 83.46% of its industry peers.
  • PLRZ has a Return On Equity of -9.70%. This is amongst the best in the industry. PLRZ outperforms 87.31% of its industry peers.
Industry RankSector Rank
ROA -9.51%
ROE -9.7%
ROIC N/A
ROA(3y)-99.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLRZ Yearly ROA, ROE, ROICPLRZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5K 10K 15K 20K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PLRZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PLRZ Yearly Profit, Operating, Gross MarginsPLRZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. PLRZ Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for PLRZ remains at a similar level compared to 1 year ago.
  • There is no outstanding debt for PLRZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PLRZ Yearly Shares OutstandingPLRZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500 1K 1.5K 2K 2.5K
PLRZ Yearly Total Debt VS Total AssetsPLRZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

  • PLRZ has an Altman-Z score of 35.61. This indicates that PLRZ is financially healthy and has little risk of bankruptcy at the moment.
  • PLRZ's Altman-Z score of 35.61 is amongst the best of the industry. PLRZ outperforms 93.46% of its industry peers.
  • There is no outstanding debt for PLRZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 35.61
ROIC/WACCN/A
WACCN/A
PLRZ Yearly LT Debt VS Equity VS FCFPLRZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

  • A Current Ratio of 44.04 indicates that PLRZ has no problem at all paying its short term obligations.
  • PLRZ has a Current ratio of 44.04. This is amongst the best in the industry. PLRZ outperforms 99.23% of its industry peers.
  • PLRZ has a Quick Ratio of 44.04. This indicates that PLRZ is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 44.04, PLRZ belongs to the top of the industry, outperforming 99.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 44.04
Quick Ratio 44.04
PLRZ Yearly Current Assets VS Current LiabilitesPLRZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. PLRZ Growth Analysis

3.1 Past

  • The earnings per share for PLRZ have decreased strongly by -207.27% in the last year.
EPS 1Y (TTM)-207.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. PLRZ Valuation Analysis

4.1 Price/Earnings Ratio

  • PLRZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PLRZ Price Earnings VS Forward Price EarningsPLRZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PLRZ Per share dataPLRZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600 -800

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PLRZ Dividend Analysis

5.1 Amount

  • PLRZ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PLRZ Fundamentals: All Metrics, Ratios and Statistics

POLYRIZON LTD

NASDAQ:PLRZ (3/6/2026, 8:00:00 PM)

13.11

-0.5 (-3.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners10%
Ins Owner ChangeN/A
Market Cap20.84M
Revenue(TTM)N/A
Net Income(TTM)-1.78M
AnalystsN/A
Price TargetN/A
Short Float %4.2%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)-807.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)-1.65
OCFYN/A
SpS0
BVpS11.56
TBVpS9.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.51%
ROE -9.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-99.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 44.04
Quick Ratio 44.04
Altman-Z 35.61
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-207.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-285.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.59%
OCF growth 3YN/A
OCF growth 5YN/A

POLYRIZON LTD / PLRZ FAQ

Can you provide the ChartMill fundamental rating for POLYRIZON LTD?

ChartMill assigns a fundamental rating of 3 / 10 to PLRZ.


What is the valuation status for PLRZ stock?

ChartMill assigns a valuation rating of 0 / 10 to POLYRIZON LTD (PLRZ). This can be considered as Overvalued.


Can you provide the profitability details for POLYRIZON LTD?

POLYRIZON LTD (PLRZ) has a profitability rating of 2 / 10.